Results 11 to 20 of about 863,963 (349)

Pseudomonas putida [PDF]

open access: yesTrends in Microbiology, 2020
Pseudomonas putida is a ubiquitous rhizosphere saprophytic bacterium and soil colonizer that belongs to the wide group of fluorescent Pseudomonas species. P. putida strain KT2440, the best-characterized member of the group, became a model laboratory species that attracted considerable attention as a cell host for synthetic biology and metabolic ...
Volke, Daniel C.   +2 more
openaire   +3 more sources

Nanotubes Formation in P. aeruginosa

open access: yesCells, 2022
The present study discusses a biofilm-positive P. aeruginosa isolate that survives at pH levels ranging from 4.0 to 9.0. The biofilm consortia were colonized with different phenotypes i.e., planktonic, slow-growing and metabolically inactive small colony
Faraz Ahmed   +10 more
doaj   +1 more source

Functional interplay between antagonistic bacteria and Rhizoctonia solani in the tomato plant rhizosphere

open access: yesFrontiers in Microbiology, 2022
Microbial interactions with plant roots play an imperial role in tomato plant growth and defense against the Rhizoctonia solani. This study performed a field experiment with two antagonistic bacteria (Pseudomonas and Bacillus) inoculated in healthy and ...
Manoj Kumar Solanki   +14 more
doaj   +1 more source

Emerging therapies against infections with Pseudomonas aeruginosa [version 1; peer review: 2 approved]

open access: yesF1000Research, 2019
Infections with Pseudomonas aeruginosa have been marked with the highest priority for surveillance and epidemiological research on the basis of parameters such as incidence, case fatality rates, chronicity of illness, available options for prevention and
Burkhard Tümmler
doaj   +1 more source

Pseudomonas mastoiditis [PDF]

open access: yesThe Laryngoscope, 1977
AbstractOpportunistic infections of the external auditory canal or the middle ear due to Pseudomonas aeruginosa occurring in patients with low resistance to infection have a 35 percent mortality rate. Once the process extends into the pneumatized temporal bone, eradication becomes more difficult and the mortality rate increases to 72 percent because of
W L, Meyerhoff   +2 more
openaire   +2 more sources

Draft Genome of Pseudomonas sp. Strain 11/12A, Isolated from Lake Washington Sediment. [PDF]

open access: yes, 2015
We announce here the genome sequencing of Pseudomonas sp. strain 11/12A from Lake Washington sediment. From the genome content, a versatile lifestyle is predicted but not one of bona fide methylotrophy.
Chistoserdova, Ludmila   +3 more
core   +1 more source

Ecthyma gangrenosum in a neonate

open access: yesIndian Journal of Paediatric Dermatology, 2020
Ecthyma gangrenosum (EG) is pathognomonic of invasive Pseudomonas infection or septicemia. It is characterized by pustules that rapidly evolve into hemorrhagic blister with central necrosis with the surrounding erythema.
Bishnupriya Sahoo   +3 more
doaj   +1 more source

Characterization of CMR5c and CMR12a, novel fluorescent Pseudomonas strains from the cocoyam rhizosphere with biocontrol activity [PDF]

open access: yes, 2007
Aim: To screen for novel antagonistic Pseudomonas strains producing both phenazines and biosurfactants that are as effective as Pseudomonas aeruginosa PNA1 in the biocontrol of cocoyam root rot caused by Pythium myriotylum.
Adiobo, Amayana   +6 more
core   +2 more sources

Perforated Shield Ulcer with Secondary Bacterial Superinfection in a Case of Severe Vernal Keratoconjunctivitis

open access: yesDelhi Journal of Ophthalmology, 2019
Secondary bacterial keratitis may rarely be associated with a shield ulcer in a case of Vernal Keratoconjunctivitis. A perforated ulcer in such a case should be promptly investigated and surgically treated immediately to prevent permanent vision loss and
Shashidhar Banigallapati   +3 more
doaj   +1 more source

Bacterial adhesion inhibitor prevents infection in a rodent surgical incision model

open access: yesVirulence, 2020
Surgical site infection risk continues to increase due to lack of efficacy in current standard of care drugs. New methods to treat or prevent antibiotic-resistant bacterial infections are needed.
R. M. Huebinger   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy